Sotorasib (Lumakras) 120 mg Price in India – Access Affordable Treatment
%20120%20mg%20Price%20in%20India%20%E2%80%93%20Access%20Affordable%20Treatment.png)
Sotorasib (Lumakras) - Introduction Sotorasib, marketed under the brand name Lumakras , is a groundbreaking therapy for patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC) . With its global approval from the US FDA and conditional approval by the European Medicines Agency (EMA) , many patients in India are seeking information about sotorasib price in India and how to safely access the medicine. Since Lumakras is not approved for commercial sale in India , patients must explore special pathways, such as the Lumakras Named Patient Program India , or work with licensed access providers to legally and safely import the drug. This guide explains how to import Lumakras to India , factors affecting treatment cost, dosing information for Lumakras 120 mg , and practical steps to ensure authenticity, all while helping patients and caregivers make informed decisions. Why Access and Cost Matter in India Accessing Lumakras 120 mg in India is challenging because the therapy is not ...